Immunovant
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunovant and other ETFs, options, and stocks.About IMVT
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It develops a novel, fully human monoclonal antibody, IMVT-1401, which selectively binds to and inhibits the neonatal fragment crystallizable receptor.
IMVT Key Statistics
Stock Snapshot
As of today, Immunovant(IMVT) shares are valued at $38.30. The company's market cap stands at 7.83B, with a P/E ratio of -13.77.
On 2026-07-02, Immunovant(IMVT) stock traded between a low of $37.74 and a high of $39.25. Shares are currently priced at $38.30, which is +1.5% above the low and -2.4% below the high.
Immunovant(IMVT) shares are trading with a volume of 828.58K, against a daily average of 2.12M.
In the last year, Immunovant(IMVT) shares hit a 52-week high of $39.28 and a 52-week low of $14.32.
In the last year, Immunovant(IMVT) shares hit a 52-week high of $39.28 and a 52-week low of $14.32.
Analyst ratings
71%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.